Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
$3.41
$3.56
$3.41
$4.22
N/AN/A550 shsN/A
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
$4.45
$4.02
$2.65
$5.00
N/AN/A1,120 shsN/A
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
$6.30
$6.30
$5.56
$6.30
N/AN/A650 shsN/A
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
$34.29
+1.9%
$30.72
$22.93
$34.29
$1.72B1.29212,067 shs211,525 shs
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
$2.14
+2.4%
$2.70
$1.78
$39.00
$3.50M0.11318,843 shs8,397 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
0.00%0.00%-3.40%-13.01%-22.85%
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
0.00%0.00%+19.30%+23.61%+122.50%
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
0.00%0.00%0.00%0.00%+8.25%
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
+5.09%+11.60%+8.72%+8.48%+36.61%
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
+0.97%-2.79%-12.55%-79.90%-94.24%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
N/AN/AN/AN/AN/AN/AN/AN/A
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
N/AN/AN/AN/AN/AN/AN/AN/A
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
N/AN/AN/AN/AN/AN/AN/AN/A
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
2.928 of 5 stars
1.54.03.30.02.01.72.5
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
N/AN/AN/AN/A
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
N/AN/AN/AN/A
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
N/AN/AN/AN/A
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
3.00
Buy$35.805.67% Upside
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/AN/AN/AN/A

Current Analyst Ratings

Latest REVB, NTB, BMDPF, BKKPF, and BXRBF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$32.00 ➝ $36.00
4/25/2024
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$34.00 ➝ $38.00
2/14/2024
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$41.00 ➝ $40.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
N/AN/AN/AN/AN/AN/A
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
N/AN/AN/AN/AN/AN/A
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
N/AN/AN/AN/AN/AN/A
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
$761.76M2.23$5.64 per share6.01$19.97 per share1.70
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/AN/AN/AN/A$25.13 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
N/A$18.470.18N/AN/AN/AN/AN/A
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
N/A-$12.40N/AN/AN/AN/AN/AN/A
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
N/A$0.847.54N/AN/AN/AN/AN/A
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
$225.49M$4.457.617.33N/A29.60%23.40%1.68%7/29/2024 (Estimated)
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
-$120K$30.410.07N/AN/AN/A-84.25%-51.31%5/27/2024 (Estimated)

Latest REVB, NTB, BMDPF, BKKPF, and BXRBF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2024Q1 2024
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
$0.96$1.17+$0.21$1.21$137.28 million$142.80 million    
3/22/2024Q4 2023
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
-$10.94-$8.33+$2.61-$8.33N/AN/A
2/13/202412/31/2023
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
$1.11$1.15+$0.04$1.19$141.34 million$146.90 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
$5.85171.55%N/A31.67%N/A
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
N/AN/AN/AN/AN/A
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
$0.314.92%N/A37.08%N/A
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
$1.765.19%N/A39.55%N/A
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/AN/AN/AN/AN/A

Latest REVB, NTB, BMDPF, BKKPF, and BXRBF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2024
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
Quarterly$0.445.23%5/6/20245/7/20245/21/2024
2/12/2024
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
Quarterly$0.445.97%2/23/20242/26/20243/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
N/AN/AN/A
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
N/AN/AN/A
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
N/AN/AN/A
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
0.10
0.63
0.63
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/A
2.18
2.18

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bangkok Bank Public Company Limited stock logo
BKKPF
Bangkok Bank Public
N/AN/AN/ANot Optionable
Banca Monte dei Paschi di Siena S.p.A. stock logo
BMDPF
Banca Monte dei Paschi di Siena
16,737N/AN/ANot Optionable
Bendigo and Adelaide Bank Limited stock logo
BXRBF
Bendigo and Adelaide Bank
4,682N/AN/ANot Optionable
The Bank of N.T. Butterfield & Son Limited stock logo
NTB
Bank of N.T. Butterfield & Son
1,33450.25 million49.65 millionNot Optionable
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
91.63 million1.63 millionNot Optionable

REVB, NTB, BMDPF, BKKPF, and BXRBF Headlines

SourceHeadline
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
businesswire.com - March 22 at 4:15 PM
Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
finance.yahoo.com - March 13 at 10:39 AM
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of GeminiRevelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
finance.yahoo.com - March 4 at 10:07 AM
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
finance.yahoo.com - February 13 at 1:07 PM
Revelation Biosciences Secures $6.2M in Public OfferingRevelation Biosciences Secures $6.2M in Public Offering
msn.com - February 9 at 5:28 PM
Revelation Biosciences Inc. Announces Closing of $6.2 Million Public OfferingRevelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
finance.yahoo.com - February 5 at 8:04 PM
Revelation Biosciences Shares Slide Premarket on Public OfferingRevelation Biosciences Shares Slide Premarket on Public Offering
marketwatch.com - February 2 at 12:49 AM
Revelation Biosciences to raise ~$6.2M through public offering of sharesRevelation Biosciences to raise ~$6.2M through public offering of shares
msn.com - February 1 at 2:49 PM
Why Is Revelation Biosciences (REVB) Stock Down 62% Today?Why Is Revelation Biosciences (REVB) Stock Down 62% Today?
investorplace.com - February 1 at 9:14 AM
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
finance.yahoo.com - January 30 at 12:55 PM
FATE, NEXI and INBS among mid-day moversFATE, NEXI and INBS among mid-day movers
seekingalpha.com - January 29 at 3:44 PM
REVB Continues March to TrialsREVB Continues March to Trials
finance.yahoo.com - January 26 at 6:25 PM
Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024
finance.yahoo.com - January 23 at 11:15 AM
Revelation Biosciences Inc Ordinary Shares REVBRevelation Biosciences Inc Ordinary Shares REVB
morningstar.com - November 22 at 2:02 PM
REVB Releases Earnings and Prepares for TrialsREVB Releases Earnings and Prepares for Trials
finance.yahoo.com - November 14 at 1:12 PM
Revelation Biosciences GAAP EPS of -$0.42Revelation Biosciences GAAP EPS of -$0.42
msn.com - November 14 at 8:12 AM
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023
finance.yahoo.com - November 13 at 5:39 PM
Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical StudiesGemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies
finance.yahoo.com - October 12 at 10:25 AM
Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities ConferenceRevelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference
finance.yahoo.com - October 4 at 1:12 PM
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of DirectorsRevelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
finance.yahoo.com - October 2 at 9:11 AM
Positive sentiment towards REVB reflected by a fall of -19.03% in short interestPositive sentiment towards REVB reflected by a fall of -19.03% in short interest
knoxdaily.com - September 7 at 8:33 PM
Revelation Biosciences Inc.’s latest rating changes from various analystsRevelation Biosciences Inc.’s latest rating changes from various analysts
knoxdaily.com - September 4 at 4:50 PM
REVB Reports Solid Balance Sheet and Remains on TrackREVB Reports Solid Balance Sheet and Remains on Track
finance.yahoo.com - August 14 at 4:02 PM
Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023
finance.yahoo.com - August 11 at 5:39 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bangkok Bank Public logo

Bangkok Bank Public

OTC:BKKPF
Bangkok Bank Public Company Limited provides various commercial banking products and services in Thailand and internationally. It operates through Domestic Banking, International Banking, Investment Banking, and Others segments. The company offers various personal banking products and services, including savings, current, fixed deposit, foreign currency, securities trading, and other accounts; home and personal loans, as well as loans for pensioners; mutual funds; bonds and debentures; life and non-life bancassurance products; payment, funds transfer, currency exchange and foreign instrument, and SMS services; debit, credit, and prepaid cards; and phone and Internet banking, mobile banking, ATMs, and other services. It also provides business banking products and services comprising operating accounts; loans for SMEs, international trade, investment banking, and e-guarantee services; securities services, such as custodian, mutual fund supervisor, provident fund registrar, securities registrar, and debenture holders' representative services; personal loans for small businesses; payment, collection, and merchant services; digital banking services; and commercial cards. In addition, the company offers trade finance, remittances, export and import, project, corporate finance, electronic services, business strategic management by trading financial instruments, and financial advisory services, as well as liquidity, fund, and asset management services. Bangkok Bank Public Company Limited was founded in 1944 and is headquartered in Bangkok, Thailand.
Banca Monte dei Paschi di Siena logo

Banca Monte dei Paschi di Siena

OTCMKTS:BMDPF
Banca Monte dei Paschi di Siena S.p.A. provides retail and commercial banking services in Italy. The company operates through Retail Banking, Corporate Banking, Wealth Management, and Large Corporate and Investment Banking segments. It offers funding and lending services, insurance products, financial advisory, and electronic payment services; financial and non-financial services; wealth management and financial planning services; consultancy services, such as tax planning, real estate, art, and legal advisory; fiduciary and trust services; and digital banking services. The company also provides leasing and factoring services for businesses, artisans, and professionals; and mid- and long-term lending, corporate finance, capital markets, and structured finance services. In addition, it offers investment banking products and services; foreign banking services; and custody and deposit services for dairy products on behalf of third parties. Further, the company develops and manages IT and telecommunication systems. The company was founded in 1472 and is headquartered in Siena, Italy.
Bendigo and Adelaide Bank logo

Bendigo and Adelaide Bank

OTCMKTS:BXRBF
Bendigo and Adelaide Bank Limited provides banking and financial products and services to retail customers and small to medium sized businesses in Australia. The company operates through Consumer, Business and Agribusiness, and Corporate segments. It offers a range of products and services, including personal and business banking, financial planning, commercial mortgages and unsecured loans, investment products, insurance, and superannuation. The company also provides retail banking products and services; home loans for the mortgage broker and mortgage manager market; rural bank products and services; wealth management services; investments and funds management services, commercial loans, access to funeral bonds, estates and trusts management services, and corporate trustee and custodial services; and banking products and services to agribusiness participants. It operates under the Bendigo Bank, AdelaideBank, Rural Bank, Community Bank, Up, Leveraged, Sandhurst Trustees, Community Enterprise Foundation, Homesafe Solutions, and Allance Bank brands. The company was founded in 1858 and is headquartered in Bendigo, Australia.
Bank of N.T. Butterfield & Son logo

Bank of N.T. Butterfield & Son

NYSE:NTB
The Bank of N.T. Butterfield & Son Limited provides a range of community, commercial, and private banking services to individuals and small to medium-sized businesses. It accepts retail and corporate checking, savings, term, and interest bearing and non-interest bearing deposits. The company's lending portfolio includes residential mortgage lending, automobile lending, consumer financing, credit cards, overdraft facilities, commercial real estate lending, and commercial and industrial loans, as well as overdraft facilities to commercial and corporate customers. It also offers investment products and services; and cash and liquidity management, foreign exchange, custody administration, and settlement services. In addition, the company provides personal and property/auto insurance products; letters of credit; and cash management, payroll, remote banking, money market, advisory, brokerage, trust, estate, company management, wealth management, and fiduciary services. Further, it offers debit and credit cards; automated teller machines; and personal and business deposit, merchant acquiring, residential and commercial mortgages, and mobile and internet banking services. The company operates through offices in the Cayman Islands, Guernsey, Jersey, the United Kingdom, The Bahamas, Switzerland, Singapore, Mauritius, and Canada. It also operates in Bermuda and the Cayman Islands. The company was founded in 1784 and is headquartered in Hamilton, Bermuda.
Revelation Biosciences logo

Revelation Biosciences

NASDAQ:REVB
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-100, a potential therapy for the prevention and treatment of healthcare-associated bacterial infection resulting from surgery, severe burns, urinary tract infection, sepsis, and antibiotic resistance; REVTx-200, a potential intranasal therapy; and REVTx-300, a potential therapy for the treatment of chronic organ disease, including chronic kidney disease. It is also developing REVTx-99b, a treatment for food allergies; REVTx-99a, an anti-viral nasal drop solution for the potential prevention or treatment of respiratory viral infection; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, influenza A, influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.